miR-322 treatment rescues cell apoptosis and neural tube defect formation through silencing NADPH oxidase 4

CNS Neurosci Ther. 2020 Sep;26(9):902-912. doi: 10.1111/cns.13383. Epub 2020 Apr 24.

Abstract

Aims: Failure of neural tube closure resulting from excessive apoptosis leads to neural tube defects (NTDs). NADPH oxidase 4 (NOX4) is a critical mediator of cell growth and death, yet its role in NTDs has never been characterized. NOX4 is a potential target of miR-322, and we have previously demonstrated that miR-322 was involved in high glucose-induced NTDs. In this study, we investigated the effect of NOX4 on the embryonic neuroepithelium in NTDs and reveal a new regulatory mechanism for miR-322 that disrupts neurulation by ameliorating cell apoptosis.

Methods: All-trans-retinoic acid (ATRA)-induced mouse model was utilized to study NTDs. RNA pull-down and dual-luciferase reporter assays were used to confirm the interaction between NOX4 and miR-322. In mouse neural stem cells and whole-embryo culture, Western blot and TUNEL were carried out to investigate the effects of miR-322 and NOX4 on neuroepithelium apoptosis in NTD formation.

Results: NOX4, as a novel target of miR-322, was upregulated in ATRA-induced mouse model of NTDs. In mouse neural stem cells, the expression of NOX4 was inhibited by miR-322; still further, NOX4-triggered apoptosis was also suppressed by miR-322. Moreover, in whole-embryo culture, injection of the miR-322 mimic into the amniotic cavity attenuated cell apoptosis in NTD formation by silencing NOX4.

Conclusion: miR-322/NOX4 plays a crucial role in apoptosis-induced NTD formation, which may provide a new understanding of the mechanism of embryonic NTDs and a basis for potential therapeutic target against NTDs.

Keywords: NADPH oxidase 4; all-trans-retinoic acid; apoptosis; miR-322; neural tube defects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • Cells, Cultured
  • Embryonic Development / physiology
  • Female
  • Gene Silencing / physiology*
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs / administration & dosage*
  • MicroRNAs / genetics
  • NADPH Oxidase 4 / antagonists & inhibitors*
  • NADPH Oxidase 4 / biosynthesis*
  • NADPH Oxidase 4 / genetics
  • Neural Tube Defects / diagnostic imaging
  • Neural Tube Defects / enzymology*
  • Neural Tube Defects / genetics
  • Neural Tube Defects / therapy
  • Treatment Outcome

Substances

  • MIRN322 microRNA, mouse
  • MicroRNAs
  • NADPH Oxidase 4
  • Nox4 protein, mouse